Last reviewed · How we verify

Passiflora ; Crataegus and Salix

Marjan Industria e Comercio ltda · Phase 3 active Small molecule

This herbal combination product works by promoting cardiovascular relaxation and mild sedation through the synergistic effects of passionflower's anxiolytic properties, hawthorn's cardiotonic effects, and willow's anti-inflammatory action.

This herbal combination product works by promoting cardiovascular relaxation and mild sedation through the synergistic effects of passionflower's anxiolytic properties, hawthorn's cardiotonic effects, and willow's anti-inflammatory action. Used for Anxiety and nervous tension, Cardiovascular support and mild hypertension.

At a glance

Generic namePassiflora ; Crataegus and Salix
Also known asPasalix
SponsorMarjan Industria e Comercio ltda
Drug classHerbal combination / Phytotherapeutic agent
ModalitySmall molecule
Therapeutic areaCardiovascular / Anxiolytic
PhasePhase 3

Mechanism of action

Passiflora (passionflower) contains alkaloids and flavonoids that modulate GABAergic neurotransmission to reduce anxiety and promote relaxation. Crataegus (hawthorn) contains flavonoids and proanthocyanidins that support cardiac function and improve coronary blood flow. Salix (willow bark) provides salicin, which has anti-inflammatory and mild analgesic properties. Together, these botanicals are intended to support cardiovascular health and emotional well-being.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: